Stanley Brendan M, Semmens James B, Lawrence-Brown Michael M D, Denton Michael, Grosser David
Repatriation General Hospital, Adelaide, South Australia.
J Endovasc Ther. 2003 Jun;10(3):511-5. doi: 10.1177/152660280301000316.
To report a series of endoluminally repaired mycotic thoracic aneurysms.
Four patients with presumed mycotic aneurysms of the thoracic aorta were treated with endovascular grafts owing to overly high risk for open repair. All aneurysms were successfully excluded at the initial intervention. In one case, which required endograft fenestrations for the superior mesenteric and renal arteries, the patient died 53 days after the procedure, following graft migration and occlusion of major branch vessels. The other 3 patients remain alive and well at a mean follow-up of 16 months with no signs of ongoing sepsis.
Endoluminal repair of thoracic mycotic aneurysms is technically feasible and, in association with long-term antibiotics, offers at least temporary protection against imminent rupture.
报告一系列腔内修复感染性胸主动脉瘤的病例。
4例疑似胸主动脉感染性动脉瘤的患者因开放修复风险过高而接受了血管腔内移植物治疗。所有动脉瘤在初次干预时均成功隔绝。其中1例因肠系膜上动脉和肾动脉需要进行腔内移植物开窗术,患者在术后53天因移植物移位和主要分支血管闭塞死亡。其他3例患者在平均16个月的随访中存活良好,无持续感染迹象。
腔内修复感染性胸主动脉瘤在技术上是可行的,并且与长期使用抗生素相结合,至少能为防止即将发生的破裂提供临时保护。